IKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Inhibikase Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.65−0.00 (-0.30%)
Close on Oct 19, 2026
- Market cap
- $287.17M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Inhibikase Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 19, 2026 | Oct 20, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2026 | Jul 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 7, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2025 | Nov 21, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2025 | Nov 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 27, 2025 | May 12, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2025 | Feb 24, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2025 | Jan 29, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 5, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 3, 2025 | Nov 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2024 | Oct 22, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2024 | Oct 10, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2024 | Oct 9, 2024 | SEC EDGAR |